MedPath

JAPANESE PROSPECTIVE REAL WORLD REGISTRY OF CABOZANTINIB PLUS NIVOLUMABIN PATIENTS WITH PREVIOUSLY UNTREATED ADVANCED OR METASTATIC RENAL CELL CARCINOMA

Not Applicable
Recruiting
Conditions
advanced or metastatic renal cell carcinoma
Registration Number
JPRN-UMIN000052855
Lead Sponsor
Kinki University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

Not applicable

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Biomarker Search
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath